NVP-TAE684 Reverses Multidrug Resistance (MDR) in Human Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function

British Journal of Pharmacology - United States
doi 10.1111/bph.13395
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley

Related search

P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma

Anticancer Research
MedicineCancer ResearchOncology
2019English

Bafetinib (INNO-406) Reverses Multidrug Resistance by Inhibiting the Efflux Function of ABCB1 and ABCG2 Transporters

Scientific Reports
Multidisciplinary
2016English

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

PLoS ONE
Multidisciplinary
2014English

Location of the Rhodamine-Binding Site in the Human Multidrug Resistance P-Glycoprotein

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

P‐Glycoprotein, Multidrug Resistance and Protein Kinase C

Oncologist
Cancer ResearchMedicineOncology
1996English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

Membrane Transport of Camptothecin: Facilitation by Human P-Glycoprotein (ABCB1) and Multidrug Resistance Protein 2 (ABCC2)

BMC Medicine
Medicine
2004English

Multidrug-Resistance P-Glycoprotein (MDR1) Secretes Platelet-Activating Factor

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2001English

Crown Ethers Reverse P-Glycoprotein-Mediated Multidrug Resistance in Cancer Cells

Scientific Reports
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy